Back

Mortality risk and treatment disparities in the Chinese SMuRF-less STEMI patients: a nationwide cohort study

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Risk predictor in acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Pengfei Sun

Tianjin Medical University General Hospital, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Comparative predictive value of SIRI and GRACE risk score for in-hospital mortality in NSTEMI patients
Doctor O. Bedir (Adana, TR)
Abstract Slides Video
Presentation thumbnail
QRS score for prediction of hemorrhagic myocardial infarction
Doctor C. Tiller (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Uncovering key predictors of diagnostic inaccuracy in acute coronary syndrome
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Comparison of GRACE, HEART and TIMI Risks to predict in hospital outcomes among the NSTEMI patients
Doctor M. CHOWDHURY (Dhaka, BD)
Abstract Slides Video
Presentation thumbnail
Identification of clinical phenotypes in type 2 myocardial infarction: insights into characteristics, prognosis and management strategies
Doctor M. Basile (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk predictor in acute coronary syndromes

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and optical coherence tomography findings in myocardial infarction patients without standard modifiable risk factors: insights from the TACTICS registry
thumbnail
Congress Presentation
High prevalence of STEMI patients without Standard Modifiable Risk Factors in a 9-year national Belgian cohort: is environmental risk the missing piece in the puzzle?
thumbnail
Congress Presentation
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources